시장보고서
상품코드
1856023

세계의 프로토카테큐산 시장 : 등급별, 형상별, 용도별, 생산 공정별, 최종 이용 산업별, 지역별 - 예측(-2030년)

Protocatechuic Acid Market By Grade, By Production, By Form, By Application, By End-use Industry And By Regional Global Forecast To 2030

발행일: | 리서치사: MarketsandMarkets | 페이지 정보: 영문 261 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

프로토카테큐산 시장 규모는 2025년 1,460만 달러에서 2030년에는 2,400만 달러로 성장하여 예측 기간 동안 CAGR은 10.5%를 기록할 것으로 예측됩니다.

조사 범위
조사 대상 연도 2021-2030년
기준 연도 2024년
예측 기간 2025-2030년
검토 단위 금액(100만 달러), 톤
부문 등급별, 형상별, 용도별, 생산량별, 최종 이용 산업별, 지역별
대상 지역 북미, 유럽, 중동 및 아프리카, 남미

세계 프로토카테큐산 시장은 건강 트렌드, 기술 발전, 산업 수요 증가로 인해 빠르게 성장하고 있습니다. 주요 촉진요인 중 하나는 암, 당뇨병, 심혈관질환, 신경 퇴행성 질환과 같은 만성질환의 유병률 상승입니다. PCA는 항산화 작용, 항염증 작용, 항암 작용, 항균 작용이 입증되어 제약 업계에서 치료 성분 및 의약 중간체로 연구 및 채택하는 사례가 증가하고 있습니다. 이와 함께 천연 소재와 식물 유래 제품을 찾는 전 세계적인 움직임은 영양 보충제 및 화장품의 수요를 촉진하고 있으며, PCA는 영양 보충제, 노화 방지 제제, 피부 보호 제품에 사용되고 있습니다.

Protocatechuic Acid Market-IMG1

초순수 등급의 프로토카테큐산은 첨단 의약품, 생명공학 및 분석 연구 분야에서 중요한 용도로 사용되기 때문에 업계에서 가장 큰 비중을 차지하고 있습니다. 이러한 분야에서는 실험, 제제, 진단 테스트의 정확성과 안전성을 보장하기 위해 99.9% 이상의 매우 우수한 순도 수준의 화합물이 요구되는 경우가 많습니다. 예를 들어, 신경 보호제 개발에서 프로토카테큐산의 항산화 특성이 활용되고 있으며, 고감도 분석에서 간섭을 피하기 위해 초순수 형태가 필요합니다. 또한, 의료 및 건강기능식품에서 천연 식물 유래의 생리활성 화합물을 중시하는 경향이 강화되고 있는 점도 고순도 프로토카테큐산의 수요를 촉진하고 있습니다. 이러한 요인들이 종합적으로 작용하여 프로토카테큐산 시장의 초순수 등급 분야의 급격한 성장에 기여하고 있습니다.

화학적 합성은 천연자원으로부터의 추출에 비해 안정적인 품질, 고순도, 확장성을 제공하기 때문에 프로토카테큐산 업계에서 가장 빠르게 성장하고 있는 생산 공정입니다. 이 방법을 통해 제조업체는 정확한 농도와 신뢰성이 중요한 의약품, 건강기능식품, 화장품 업계의 증가하는 수요를 충족시킬 수 있습니다. 또한, 화학 합성은 계절적 식물 공급원에 대한 의존도를 줄이고, 생산 비용을 낮추며, 대규모 산업 생산을 가능하게 하고, 시장의 증가하는 수요를 효율적으로 충족시킬 수 있는 바람직한 방법이 되고 있습니다.

프로토카테큐산의 분말/결정 형태는 실용적, 기능적, 경제적 이점이 결합되어 업계에서 가장 빠르게 성장하는 분야로 부상하고 있습니다. 액상이나 과립형과 달리 결정형은 화학적 안정성이 우수하고 보존 기간이 길어 제품의 효능을 장기간 유지해야 하는 의약품, 건강기능식품, 화장품 용도에 필수적입니다. 고농도의 균일한 특성으로 정확한 투여가 가능하며, 정제, 캡슐, 건강기능식품 등의 제형에서 일관된 성능을 보장합니다. 또한, 분말/결정 형태는 운송, 보관, 취급이 용이하여 물류상의 문제를 줄이고, 액체에 비해 열화 위험을 최소화할 수 있습니다. 특히 항산화 및 신경 보호와 관련된 섬세한 실험에서 정확한 측정과 재현 가능한 결과를 쉽게 얻을 수 있기 때문에 연구 및 분석 장면에서 이 형태가 특히 선호됩니다. 또한, 산업적 규모의 생산으로 전환하는 추세와 고순도 식물 유래 생리활성 화합물에 대한 수요 증가로 인해 분말 및 결정 형태의 채택이 더욱 가속화되고 있습니다. 이러한 매력으로 인해 프로토카테큐산 시장에서 분말 및 결정체 부문이 가장 매력적이고 빠르게 성장하고 있습니다.

아시아태평양은 인구통계학적, 경제적, 기술적, 규제적 요인이 복합적으로 작용하여 시장 확대를 위한 비옥한 토양을 조성함으로써 프로토카테큐산 시장에서 가장 빠르게 성장하는 지역으로 부상하고 있습니다. 이 지역은 세계 최고 수준의 인구를 자랑하며, 인도, 중국, 아세안 국가 등은 급속한 도시화를 경험하고 있어 건강 및 웰니스 제품의 소비자층이 크게 확대되고 있습니다. 이러한 인구통계학적 변화는 급증하는 중산층의 증가와 가처분 소득의 증가로 인해 건강 지향적인 라이프스타일로의 뚜렷한 전환을 촉진하고, 의약품, 건강보조식품, 화장품에서 PCA와 같은 천연 생리활성 물질에 대한 수요를 증가시키고 있습니다. 이 지역의 소비자들은 항산화, 항염증, 항균 작용이 입증된 제품을 점점 더 선호하고 있으며, PCA를 기능성 식품, 영양 보충제, 스킨케어 제제의 귀중한 성분으로 인식하고 있습니다.

세계의 프로토카테큐산 시장에 대해 조사했으며, 등급별, 형태별, 용도별, 생산 공정별, 최종 이용 산업별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

  • 소개
  • 시장 역학
  • 생성형 AI의 영향

제6장 업계 동향

  • 소개
  • 고객 비즈니스에 영향을 미치는 동향/혼란
  • 공급망 분석
  • 가격 분석
  • 투자 상황과 자금 조달 시나리오
  • 생태계 분석
  • 기술 분석
  • 2025년 미국 관세가 프로토카테큐산 시장에 미치는 영향
  • 특허 분석
  • 무역 분석
  • 2025-2026년의 주요 회의와 이벤트
  • 관세와 규제 상황
  • Porter's Five Forces 분석
  • 주요 이해관계자와 구입 기준
  • 거시경제 전망
  • 사례 연구 분석

제7장 프로토카테큐산 시장(등급별)

  • 소개
  • 초고순도 등급
  • 산업용 등급
  • 저등급

제8장 프로토카테큐산 시장(형상별)

  • 소개
  • 분말/결정
  • 과립
  • 액체
  • 기타

제9장 프로토카테큐산 시장(생산 공정별)

  • 소개
  • 화학 합성
  • 천연 추출/바이오 기반

제10장 프로토카테큐산 시장(용도별)

  • 소개
  • 방부제와 산화방지제
  • 화학 중간체
  • 폴리머
  • 염료
  • 사료첨가물 및 뉴트라슈티컬
  • 방청제
  • 기타

제11장 프로토카테큐산 시장(최종 이용 산업별)

  • 소개
  • 의약품
  • 식품 및 음료
  • 화장품/퍼스널케어
  • 농업
  • 기타

제12장 프로토카테큐산(지역별)

  • 소개
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 기타
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 이탈리아
    • 프랑스
    • 영국
    • 스페인
    • 기타
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타
  • 남미
    • 브라질
    • 아르헨티나
    • 기타

제13장 경쟁 구도

  • 소개
  • 주요 진출 기업의 전략/강점
  • 시장 점유율 분석
  • 매출 분석
  • 브랜드/제품 비교 분석
  • 기업 평가 매트릭스(주요 진출 기업), 2024년
  • 스타트업/중소기업용 기업 평가 매트릭스(2024년)
  • 경쟁 시나리오

제14장 기업 개요

  • 주요 진출 기업
    • VERTEXYN(NANJING) BIOWORKS
    • GREEN CHEMICALS CO., LTD.
    • NANJING NUTRIHERB BIOTECH CO., LTD.
    • SHAANXI LONIERHERB BIO-TECHNOLOGY CO., LTD.
    • SIMSON PHARMA LIMITED
    • CENTRAL DRUG HOUSE
    • CAYMAN CHEMICAL COMPANY
    • TAIZHOU ZHONGDA CHEMICAL CO., LTD.
    • HANGZHOU VIABLIFE BIOTECH CO., LTD.
    • CHEMFACES
  • 기타 기업
    • ANANT PHARMACEUTICALS PVT. LTD.
    • JINAN FINER CHEMICAL CO.
    • OTTO CHEMIE PVT. LTD.
    • SIGMA-ALDRICH
    • BIOSYNTH
    • AXIOM CHEMICALS PVT. LTD.
    • PHARMAFFILIATES PRIVATE LIMITED
    • BLDPHARM
    • SELLECK CHEMICALS
    • LKT LABORATORIES

제15장 부록

KSM 25.11.10

The protocatechuic acid market size is projected to grow from USD 14.6 million in 2025 to USD 24.0 million by 2030, registering a CAGR of 10.5% during the forecast period.

Scope of the Report
Years Considered for the Study2021-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million), Volume (Tons)
SegmentsGrade, production process, Application, End-use Industry, and Region.
Regions coveredNorth America, Europe, Middle East & Africa, and South America.

The global protocatechuic acid market is experiencing rapid growth due to a combination of health trends, technological advancements, and increasing industrial demand. One of the primary drivers is the rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and neurodegenerative conditions. Since PCA has been proven to have antioxidant, anti-inflammatory, anticancer, and antimicrobial properties, it is increasingly being studied and adopted in the pharmaceutical industry as a therapeutic ingredient and drug intermediate. Alongside this, the global push toward natural and plant-based products is fueling demand in nutraceuticals and cosmetics, where PCA is used in dietary supplements, anti-aging formulations, and skin-protective products.

Protocatechuic Acid Market - IMG1

"Ultra-high purity grade is projected to be the largest segment in the grade segment of the protocatechuic acid market in terms of value."

The ultra-high purity grade of protocatechuic acid is the largest segment in the industry due to its critical applications in advanced pharmaceuticals, biotechnology, and analytical research. These sectors demand compounds with exceptional purity levels-often exceeding 99.9%-to ensure the accuracy and safety of experiments, drug formulations, and diagnostic tests. For instance, in the development of neuroprotective agents, protocatechuic acid's antioxidant properties are harnessed, necessitating ultra-pure forms to avoid interference in sensitive assays. Additionally, the increasing emphasis on natural, plant-derived bioactive compounds in medicine and nutraceuticals further propels the demand for high-purity protocatechuic acid, as it is considered safer and more effective than synthetic alternatives. These factors collectively contribute to the rapid growth of the ultra-high purity grade segment in the protocatechuic acid market.

"Chemical synthesis is anticipated to be the fastest-growing segment in production process segment of the protocatechuic acid market in terms of value."

Chemical synthesis is the fastest-growing production process in the protocatechuic acid industry because it offers consistent quality, high purity, and scalability compared to extraction from natural sources. This method allows manufacturers to meet the increasing demand from the pharmaceuticals, nutraceuticals, and cosmetic industries, where precise concentration and reliability are critical. Additionally, chemical synthesis reduces dependency on seasonal plant sources, lowers production costs, and enables large-scale industrial production, making it a preferred method for meeting the market's growing requirements efficiently.

"Powder/ Crystalline is the fastest growing segment of the protocatechuic acid market in terms of value."

The powder/ crystalline form of protocatechuic acid has emerged as the fastest-growing segment in the industry due to a combination of practical, functional, and economic advantages. Unlike liquid or granular forms, the crystalline form offers superior chemical stability and a longer shelf life, which is critical for pharmaceutical, nutraceutical, and cosmetic applications where product efficacy must be maintained over time. Its highly concentrated and uniform nature allows for precise dosing, ensuring consistent performance in formulations such as tablets, capsules, and dietary supplements. Moreover, the powder/crystalline form is easier to transport, store, and handle, reducing logistical challenges and minimizing degradation risks compared to liquids. In research and analytical contexts, this form is particularly preferred because it facilitates accurate measurement and reproducible results in sensitive experiments, especially those related to antioxidant or neuroprotective studies. Furthermore, the increasing trend toward industrial-scale production and the growing demand for high-purity, plant-derived bioactive compounds further amplify the adoption of the powder and crystalline forms. Collectively, these factors make the powder/crystalline segment the most attractive and rapidly expanding option in the protocatechuic acid market.

"Asia Pacific is the fastest growing region in the protocatechuic acid market in terms of value."

Asia-Pacific stands out as the fastest-growing region in the protocatechuic acid market due to a confluence of demographic, economic, technological, and regulatory factors that create a fertile ground for market expansion. The region boasts one of the largest populations globally, with countries like India, China, and the ASEAN nations experiencing rapid urbanization, which has significantly expanded the consumer base for health and wellness products. This demographic shift is accompanied by a burgeoning middle class, whose rising disposable incomes are driving a pronounced shift toward health-conscious lifestyles, increasing the demand for natural bioactives such as PCA in pharmaceuticals, nutraceuticals, and cosmetics. The region's consumers are increasingly favoring products with proven antioxidant, anti-inflammatory, and antimicrobial properties, positioning PCA as a valuable ingredient in functional foods, dietary supplements, and skincare formulations.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the protocatechuic acid market, and information was gathered from secondary research to determine and verify the market size of several segments.

  • By Company Type: Tier 1 - 50%, Tier 2 - 30%, and Tier 3 - 20%
  • By Designation: Managers- 15%, Directors - 20%, and Others - 65%
  • By Region: North America - 25%, Europe - 15%, Asia Pacific - 45%, Middle East & Africa - 10%, South America - 5%.

The protocatechuic acid market comprises Vertexyn Bioworks Co., Ltd. (China), Green Chemicals Co., Ltd. (GCC) (Japan), Nanjing NutriHerb BioTech Co.,Ltd (China), Shaanxi LonierHerb Bio-Technology Co., Ltd. (China), SimSon Pharma Limited (China), Central Drug House (India), Cayman Chemical (US), Taizhou Zhongda Chemical Co., Ltd. (China), Hangzhou Viablife Biotech Co., Ltd. (China), ChemFaces (China). The study includes an in-depth competitive analysis of these key players in the protocatechuic acid market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This report segments the market for protocatechuic acid on the basis of form, production process, grade, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products & services, key strategies, and expansions associated with the protocatechuic acid market.

Key benefits of buying this report

This research report is focused on various levels of analysis - industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape; emerging and high-growth segments of the protocatechuic acid market; high-growth region; and market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of drivers: (Rising consumer preferences towards Natural Antioxidants & Clean Label Products), restraints (Constrained competition from the substituted products in the industry), opportunities (From Plastic Waste to Bioactive Wealth: PET-to-PCA Upcycling for a Sustainable Future), and challenges (Limited Industrial-Scale Applications of PCA due to high costs, low yields, and regulatory barriers for PCA).
  • Market Penetration: Comprehensive information on the protocatechuic acid market is offered by top players in the market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, partnerships, agreements, joint ventures, collaboration, announcements, awards, and expansion in the market.
  • Market Development: Comprehensive information about lucrative emerging markets, the report analyzes the markets for protocatechuic acid across regions.
  • Market Capacity: Production capacities of companies producing protocatechuic acid are provided wherever available, with upcoming capacities for the protocatechuic acid market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the protocatechuic acid market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key primary sources
      • 2.1.2.3 Key participants in primary interviews
      • 2.1.2.4 Breakdown of primary interviews
      • 2.1.2.5 Key industry insights
  • 2.2 BASE NUMBER CALCULATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS
    • 2.2.2 DEMAND-SIDE ANALYSIS
  • 2.3 MARKET SIZE FORECAST
    • 2.3.1 SUPPLY SIDE
    • 2.3.2 DEMAND SIDE
  • 2.4 MARKET SIZE ESTIMATION
    • 2.4.1 BOTTOM-UP APPROACH
    • 2.4.2 TOP-DOWN APPROACH
  • 2.5 DATA TRIANGULATION
  • 2.6 FACTOR ANALYSIS
  • 2.7 RESEARCH ASSUMPTIONS
  • 2.8 RESEARCH LIMITATIONS
  • 2.9 GROWTH FORECAST
  • 2.10 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PROTOCATECHUIC ACID MARKET
  • 4.2 PROTOCATECHUIC ACID MARKET, BY GRADE
  • 4.3 PROTOCATECHUIC ACID MARKET, BY FORM
  • 4.4 PROTOCATECHUIC ACID MARKET, BY PRODUCTION PROCESS
  • 4.5 PROTOCATECHUIC ACID MARKET, BY APPLICATION
  • 4.6 PROTOCATECHUIC ACID MARKET, BY END-USE INDUSTRY
  • 4.7 PROTOCATECHUIC ACID MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising consumer preferences toward natural antioxidants & clean-label products
      • 5.2.1.2 Growing demand in expanding cosmetics & personal care industry
      • 5.2.1.3 PCA used as bioactives for sustainable agriculture and crop protection adoption
      • 5.2.1.4 Regulatory frameworks supporting application in nutraceuticals industry
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Competition posed by established phenolics
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 PET-to-PCA upcycling for sustainable future
      • 5.2.3.2 Green extraction technologies unlocking sustainable opportunities for protocatechuic acid innovation
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Limited industrial-scale applications due to high costs, low yields, and regulatory barriers
  • 5.3 IMPACT OF GENERATIVE AI
    • 5.3.1 INTRODUCTION
    • 5.3.2 IMPACT OF GENERATIVE AI ON PROTOCATECHUIC ACID MARKET

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.3 SUPPLY CHAIN ANALYSIS
    • 6.3.1 RAW MATERIAL & FEEDSTOCK SOURCING
    • 6.3.2 CONVERSION & PRODUCTION
    • 6.3.3 PURIFICATION, MODIFICATION, AND MANUFACTURING
    • 6.3.4 DISTRIBUTION & END-USE INDUSTRIES
  • 6.4 PRICING ANALYSIS
    • 6.4.1 AVERAGE SELLING PRICE, BY REGION, 2021-2024
    • 6.4.2 AVERAGE SELLING PRICE, BY GRADE, 2021-2024
    • 6.4.3 AVERAGE SELLING PRICE, BY GRADE, 2021-2024
    • 6.4.4 AVERAGE SELLING PRICE, BY KEY PLAYERS AND GRADE, 2021-2024
  • 6.5 INVESTMENT LANDSCAPE AND FUNDING SCENARIO
  • 6.6 ECOSYSTEM ANALYSIS
  • 6.7 TECHNOLOGY ANALYSIS
    • 6.7.1 KEY TECHNOLOGIES
    • 6.7.2 COMPLEMENTARY TECHNOLOGIES
    • 6.7.3 ADJACENT TECHNOLOGIES
  • 6.8 IMPACT OF 2025 US TARIFFS ON PROTOCATECHUIC ACID MARKET
    • 6.8.1 INTRODUCTION
    • 6.8.2 KEY TARIFF RATES
    • 6.8.3 PRICE IMPACT ANALYSIS
    • 6.8.4 IMPACT ON COUNTRY/REGION
      • 6.8.4.1 US
      • 6.8.4.2 Europe
      • 6.8.4.3 Asia Pacific
    • 6.8.5 IMPACT ON END-USE INDUSTRIES
  • 6.9 PATENT ANALYSIS
    • 6.9.1 METHODOLOGY
    • 6.9.2 PATENTS GRANTED WORLDWIDE, 2015-2024
    • 6.9.3 PATENT PUBLICATION TRENDS
    • 6.9.4 INSIGHTS
    • 6.9.5 LEGAL STATUS OF PATENTS
    • 6.9.6 JURISDICTION ANALYSIS
    • 6.9.7 TOP APPLICANTS
    • 6.9.8 LIST OF MAJOR PATENTS
  • 6.10 TRADE ANALYSIS
    • 6.10.1 IMPORT SCENARIO (HS CODE 291829)
    • 6.10.2 EXPORT SCENARIO (HS CODE 291829)
  • 6.11 KEY CONFERENCES AND EVENTS, 2025-2026
  • 6.12 TARIFF AND REGULATORY LANDSCAPE
    • 6.12.1 TARIFFS RELATED TO PROTOCATECHUIC ACID MARKET
    • 6.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.12.3 REGULATIONS RELATED TO PROTOCATECHUIC ACID MARKET
  • 6.13 PORTER'S FIVE FORCES ANALYSIS
    • 6.13.1 THREAT OF NEW ENTRANTS
    • 6.13.2 THREAT OF SUBSTITUTES
    • 6.13.3 BARGAINING POWER OF SUPPLIERS
    • 6.13.4 BARGAINING POWER OF BUYERS
    • 6.13.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 6.14.2 BUYING CRITERIA
  • 6.15 MACROECONOMIC OUTLOOK
    • 6.15.1 GDP TRENDS AND FORECASTS, BY COUNTRY
  • 6.16 CASE STUDY ANALYSIS
    • 6.16.1 ENGINEERING BACILLUS LICHENIFORMIS FOR SUSTAINABLE PRODUCTION OF PROTOCATECHUIC ACID FROM GLUCOSE
    • 6.16.2 DEVELOPMENT OF ASPERGILLUS NIGER CELL FACTORY FOR PRODUCING PROTOCATECHUIC ACID FROM PLANT-DERIVED AROMATICS
    • 6.16.3 PROTOCATECHUIC ACID AS NATURAL FEED ADDITIVE ENHANCING POULTRY HEALTH AND PERFORMANCE

7 PROTOCATECHUIC ACID MARKET, BY GRADE

  • 7.1 INTRODUCTION
  • 7.2 ULTRA-HIGH PURITY GRADE
    • 7.2.1 ENSURES PRECISION, SAFETY, AND REGULATORY COMPLIANCE IN CRITICAL APPLICATIONS
  • 7.3 INDUSTRIAL GRADE
    • 7.3.1 REDUCES MICROBIAL GROWTH IN FOOD PRODUCTS
  • 7.4 LOWER GRADE
    • 7.4.1 ACTS AS NATURAL PRESERVATIVE IN ANIMAL FEED

8 PROTOCATECHUIC ACID MARKET, BY FORM

  • 8.1 INTRODUCTION
  • 8.2 POWDER/ CRYSTALLINE
    • 8.2.1 PROVIDES LONG SHELF LIFE AND STABILITY UNDER STORAGE CONDITIONS
  • 8.3 GRANULES
    • 8.3.1 EASY TO MEASURE AND OFFER CONTROLLED DISSOLUTION RATES COMPARED TO POWDER
  • 8.4 LIQUID
    • 8.4.1 GROWING USE IN COSMETICS AND AGRICULTURE INDUSTRIES TO DRIVE DEMAND
  • 8.5 OTHER FORMS

9 PROTOCATECHUIC ACID MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 CHEMICAL SYNTHESIS
    • 9.2.1 DOMINANCE DRIVEN BY WELL-DEVELOPED SUPPLY CHAIN
  • 9.3 NATURAL EXTRACTION/ BIO-BASED
    • 9.3.1 CUTS GREENHOUSE GAS EMISSIONS BY UP TO 40%

10 PROTOCATECHUIC ACID MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 PRESERVATIVES & ANTIOXIDANTS
    • 10.2.1 PROTOCATECHUIC ACID REPLACING SYNTHETIC ANTIOXIDANTS
    • 10.2.2 FOOD PRESERVATIVES
    • 10.2.3 COSMETIC PRESERVATIVES
    • 10.2.4 INDUSTRIAL ANTIOXIDANTS
  • 10.3 CHEMICAL INTERMEDIATES
    • 10.3.1 PROTOCATECHUIC ACID FACILITATES PRODUCTION OF BIOACTIVE COMPOUNDS
    • 10.3.2 PHARMACEUTICAL INTERMEDIATES
    • 10.3.3 AGROCHEMICAL INTERMEDIATES
    • 10.3.4 SPECIALTY CHEMICAL INTERMEDIATES
  • 10.4 POLYMERS
    • 10.4.1 MULTI-FUNCTIONAL BIO-BASED COMPOUND MAKES PROTOCATECHUIC ACID DIFFERENT FROM CONVENTIONAL PETROCHEMICAL ADDITIVES
    • 10.4.2 POLYMER ADDITIVES
    • 10.4.3 RESIN MODIFIERS
    • 10.4.4 PLASTIC STABILIZERS
  • 10.5 DYES
    • 10.5.1 PROTOCATECHUIC ACID ENHANCES LIGHTFASTNESS AND IMPROVES ANTHRAQUINONE DYE PERFORMANCE BY UP TO TWO GRADES
    • 10.5.2 TEXTILE DYES
    • 10.5.3 LEATHER DYES
    • 10.5.4 INK COLORANTS
  • 10.6 FEED ADDITIVES & NUTRACEUTICALS
    • 10.6.1 PROTOCATECHUIC ACID EMERGING AS CLEAN-LABELED NUTRACEUTICAL INGREDIENT
    • 10.6.2 ANIMAL FEED ADDITIVES
    • 10.6.3 NUTRITIONAL SUPPLEMENTS
    • 10.6.4 FUNCTIONAL HEALTH INGREDIENTS
  • 10.7 RUST INHIBITORS
    • 10.7.1 PROTOCATECHUIC ACID EMERGING AS KEY NATURAL COMPONENT IN MODERN CORROSION PREVENTION TECHNOLOGIES
    • 10.7.2 METAL COATINGS
    • 10.7.3 INDUSTRIAL LUBRICANT ADDITIVES
    • 10.7.4 CORROSION PROTECTION SOLUTIONS
  • 10.8 OTHER APPLICATIONS
    • 10.8.1 ADHESIVES

11 PROTOCATECHUIC ACID MARKET, BY END-USE INDUSTRY

  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICALS
    • 11.2.1 ANTI-INFLAMMATORY AND MULTIFACETED PROPERTY OF PROTOCATECHUIC ACID TO DRIVE DEMAND
  • 11.3 FOOD & BEVERAGES
    • 11.3.1 GROWING DEMAND FOR NATURAL PRESERVATIVES TO INFLUENCE GROWTH
  • 11.4 COSMETICS/ PERSONAL CARE
    • 11.4.1 GLOBAL GREEN BEAUTY MOVEMENT TO EXPAND DEMAND
  • 11.5 AGRICULTURE
    • 11.5.1 GROWING EMPHASIS ON SUSTAINABLE FARMING PRACTICES TO DRIVE MARKET
  • 11.6 OTHER END-USE INDUSTRIES
    • 11.6.1 TEXTILES

12 PROTOCATECHUIC ACID, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 ASIA PACIFIC
    • 12.2.1 CHINA
      • 12.2.1.1 Government promoting integration of herbal and plant-derived ingredients into mainstream healthcare to drive market
    • 12.2.2 JAPAN
      • 12.2.2.1 Focus on functional foods and strict regulatory oversight to drive market
    • 12.2.3 INDIA
      • 12.2.3.1 Government-backed initiatives promoting natural healthcare to drive market
    • 12.2.4 SOUTH KOREA
      • 12.2.4.1 Growth of K-Health exports and biotechnology support to drive market
    • 12.2.5 REST OF ASIA PACIFIC
  • 12.3 NORTH AMERICA
    • 12.3.1 US
      • 12.3.1.1 Stringent regulatory frameworks to drive market
    • 12.3.2 CANADA
      • 12.3.2.1 Growing consumer preference for clean-label and natural ingredients to drive market
    • 12.3.3 MEXICO
      • 12.3.3.1 Increasing use of protocatechuic acid in dietary supplements to drive market
  • 12.4 EUROPE
    • 12.4.1 GERMANY
      • 12.4.1.1 Shift to eco-friendly, bio-based production to drive demand
    • 12.4.2 ITALY
      • 12.4.2.1 Sustainability commitment by domestic manufacturers to drive market
    • 12.4.3 FRANCE
      • 12.4.3.1 Growing demand for natural extracts in pharmaceuticals industry to drive market
    • 12.4.4 UK
      • 12.4.4.1 Ongoing research on antimicrobial and neuroprotective applications of protocatechuic acid to drive market
    • 12.4.5 SPAIN
      • 12.4.5.1 Favorable climate and adherence to stringent regulations to drive market
    • 12.4.6 REST OF EUROPE
  • 12.5 MIDDLE EAST & AFRICA
    • 12.5.1 GCC COUNTRIES
      • 12.5.1.1 Saudi Arabia
        • 12.5.1.1.1 Saudi Green Initiative to drive growth
      • 12.5.1.2 UAE
        • 12.5.1.2.1 Strong incentives and policies supporting sustainability initiatives to drive market
      • 12.5.1.3 Rest of GCC countries
    • 12.5.2 SOUTH AFRICA
      • 12.5.2.1 Focus on indigenous herbal medicines to drive market
    • 12.5.3 REST OF MIDDLE EAST & AFRICA
  • 12.6 SOUTH AMERICA
    • 12.6.1 BRAZIL
      • 12.6.1.1 Focus on sustainable agroforestry to drive market
    • 12.6.2 ARGENTINA
      • 12.6.2.1 Growing focus on natural health products to drive demand
    • 12.6.3 REST OF SOUTH AMERICA

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 13.3 MARKET SHARE ANALYSIS
    • 13.3.1 MARKET RANKING ANALYSIS
  • 13.4 REVENUE ANALYSIS
  • 13.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 13.6 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
    • 13.6.1 STARS
    • 13.6.2 EMERGING LEADERS
    • 13.6.3 PERVASIVE PLAYERS
    • 13.6.4 PARTICIPANTS
    • 13.6.5 COMPANY FOOTPRINT
  • 13.7 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2024
    • 13.7.1 PROGRESSIVE COMPANIES
    • 13.7.2 RESPONSIVE COMPANIES
    • 13.7.3 DYNAMIC COMPANIES
    • 13.7.4 STARTING BLOCKS
    • 13.7.5 COMPETITIVE BENCHMARKING
      • 13.7.5.1 List of key startups/SMEs
    • 13.7.6 PROTOCATECHUIC ACID MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
      • 13.7.6.1 Competitive benchmarking of key startups/SMEs
    • 13.7.7 VALUATION AND FINANCIAL METRICS OF KEY PROTOCATECHUIC ACID VENDORS
  • 13.8 COMPETITIVE SCENARIO
    • 13.8.1 PRODUCT LAUNCHES

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 VERTEXYN (NANJING) BIOWORKS
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Solutions/Services offered
      • 14.1.1.3 MnM view
        • 14.1.1.3.1 Right to win
        • 14.1.1.3.2 Strategic choices
        • 14.1.1.3.3 Weaknesses and competitive threats
    • 14.1.2 GREEN CHEMICALS CO., LTD.
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Solutions/Services offered
      • 14.1.2.3 MnM view
        • 14.1.2.3.1 Right to win
        • 14.1.2.3.2 Strategic choices
        • 14.1.2.3.3 Weaknesses and competitive threats
    • 14.1.3 NANJING NUTRIHERB BIOTECH CO., LTD.
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Solutions/Services offered
      • 14.1.3.3 MnM view
        • 14.1.3.3.1 Right to win
        • 14.1.3.3.2 Strategic choices
        • 14.1.3.3.3 Weaknesses and competitive threats
    • 14.1.4 SHAANXI LONIERHERB BIO-TECHNOLOGY CO., LTD.
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Solutions/Services offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Right to win
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses and competitive threats
    • 14.1.5 SIMSON PHARMA LIMITED
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Solutions/Services offered
      • 14.1.5.3 MnM view
        • 14.1.5.3.1 Right to win
        • 14.1.5.3.2 Strategic choices
        • 14.1.5.3.3 Weaknesses and competitive threats
    • 14.1.6 CENTRAL DRUG HOUSE
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Solutions/Services offered
    • 14.1.7 CAYMAN CHEMICAL COMPANY
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Solutions/Services offered
    • 14.1.8 TAIZHOU ZHONGDA CHEMICAL CO., LTD.
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Solutions/Services offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product launches
    • 14.1.9 HANGZHOU VIABLIFE BIOTECH CO., LTD.
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products/Solutions/Services offered
    • 14.1.10 CHEMFACES
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products/Solutions/Services offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 ANANT PHARMACEUTICALS PVT. LTD.
    • 14.2.2 JINAN FINER CHEMICAL CO.
    • 14.2.3 OTTO CHEMIE PVT. LTD.
    • 14.2.4 SIGMA-ALDRICH
    • 14.2.5 BIOSYNTH
    • 14.2.6 AXIOM CHEMICALS PVT. LTD.
    • 14.2.7 PHARMAFFILIATES PRIVATE LIMITED
    • 14.2.8 BLDPHARM
    • 14.2.9 SELLECK CHEMICALS
    • 14.2.10 LKT LABORATORIES

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제